The Centers for Medicare and Medicaid Services at the same time proposed coverage of the F1CDx test from Foundation Medicine, which detects genetic mutations in 324 genes and two genomic signatures in any solid tumor type.
Read More
POC testing is unlocking new markets for commercial IVDs, but reaching potential new customers can be a challenge.
Read More
Alinity ci series instruments for clinical chemistry and immunoassay diagnostics were designed to help labs address modern diagnostic sector challenges—including aging populations, increased incidence of chronic diseases under management, and increased access to care—that are driving increases in testing volume.
Read More
Vantari Genetics and Translational Software have partnered to provide genotype testing, actionable genomic information, and custom reporting in support of the GeneMatch registry at Banner Alzheimer’s Institute.
Read More
Quest Diagnostics has approved a definitive agreement to acquire Cleveland HeartLab, with the intent of establishing a national center of excellence in heart disease diagnostic information services.
Read More